MedTrace Logo

Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation

NCT07140562 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-08-24

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the safety and technical success of the Tangent Tricuspid Annular Therapy System in patients with severe, symptomatic functional tricuspid regurgitation.

Conditions

  • Tricuspid Regurgitation Functional
  • Tricuspid Regurgitation (TR)
  • Tricuspid Regurgitation

Interventions

DEVICE

Tricuspid Annular Therapy System

A transcatheter device designed for tricuspid valve repair.

Sponsors & Collaborators

  • Tangent Cardiovascular Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-15
Primary Completion
2026-01-31
Completion
2026-12-31

Countries

  • Paraguay

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07140562 on ClinicalTrials.gov